[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"focus-on-axial-length\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:focus-on-axial-length":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":5},"100628042","phase-2-the-effect-of-001-atropine-eye-drops-on-axial-length-and-refraction-in-myopic-children-compared-to-a-control-group-100628042",false,"NCT07456488","The Effect of 0.01% Atropine Eye Drops on Axial Length and Refraction in Myopic Children Compared to a Control Group","Inclusion Criteria:\n\n* Children aged 4-16 years\n* Both genders\n* Myopia of baseline SER of -1.00D or more\n* Astigmatism less than or equal to -2.50D\n* No medical history predisposing severe myopia (e.g., Marfan syndrome, Stickler syndrome, and retinopathy of prematurity), abnormal ocular refractive anatomy (e.g., keratoconus, lenticonus, and spherophakia)\n* No history of other vision-threatening ocular diseases or previous intraocular surgery.\n* No current or previous use of atropine or pirenzipine, contact lenses or other forms of treatment that may affect myopia progression.\n\nExclusion Criteria:\n\n* Astigmatism ≥ 2.5 D\n* Anisometropia\\>1 D\n* Best corrected visual acuity \\\u003C 0.5 (6\u002F12)\n* Prior intraocular surgery\n* Allergy to atropine eye drops\n* Systemic diseases associated with myopia such as Marfan syndrome, Stickler syndrome\n* History of cardiac or significant respiratory diseases\n* Lack of consent for participating in the study","ALL","4 Years","16 Years",{"count":19,"type":20},60,"ESTIMATED","INTERVENTIONAL",[23],"PHASE2","In this study, atropine 0.01% eye drops will be given to myopic children once at night daily for 6 months as compared to a control group to see the effect on axial length and refraction",[26],"Focus on Axial Length","RECRUITING","2026-03-03",{"date":30,"type":31},"2026-03-06","ACTUAL",{"date":33,"type":31},"2025-07-13",{"date":35,"type":20},"2026-04-30",{"name":37,"class":38},"Liaquat National Hospital & Medical College","OTHER"]